Double Refractory News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Double Refractory. Real-time updates on events, politics, business and more.

Lamanna Details Evolution of CLL Treatment Following Resistance

November 9, 2023

Nicole Lamanna, MD, discusses treatment options for patients with chronic lymphocytic leukemia who develop resistance to a prior treatment.

New York United States Eli Lilly Nicole Lamanna Presbyterian Columbia University Medical Center International Conference On Malignant Lymphoma

Source: onclive.com

Affimed Provides Updated Clinical Data from Phase 1/2 Study

December 10, 2022

AFM13 in combination with NK cells shows very high overall and complete response rates in 41 heavily pre-treated CD30-positive Hodgkin lymphoma (HL) and...

Baden Wüberg New York United States Alex Fudukidis Adi Hoess Andreas Harstrick

Source: globenewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Double Refractory News Today

Lamanna Details Evolution of CLL Treatment Following Resistance

Affimed Provides Updated Clinical Data from Phase 1/2 Study

Explore More Categories